(1->4)-beta-D-glucan multiple interactions ISO RGD:737063 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PRKCA mRNA CTD PMID:36331819 (5Z,8Z,11Z,13E)-15-HETE multiple interactions ISO RGD:737062 6480464 15-hydroxy-5 more ... CTD PMID:15613483 (5Z,8Z,11Z,13E)-15-HETE multiple interactions ISO RGD:737063 6480464 calphostin C inhibits the reaction [15-hydroxy-5 more ... CTD PMID:15451026 (5Z,8Z,11Z,13E)-15-HETE affects localization ISO RGD:737062 6480464 15-hydroxy-5 more ... CTD PMID:15613483 (5Z,8Z,11Z,13E)-15-HETE increases activity ISO RGD:737063 6480464 15-hydroxy-5 more ... CTD PMID:15451026 (9R)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dione affects response to substance ISO RGD:737063 6480464 PRKCA affects the susceptibility to ruboxistaurin CTD PMID:19556521 (S)-naringenin multiple interactions ISO RGD:737062 6480464 [naringenin co-treated with bisphenol A] results in increased expression of PRKCA mRNA more ... CTD PMID:25866363 , PMID:36235125 (S)-nicotine increases activity ISO RGD:737062 6480464 Nicotine results in increased activity of PRKCA protein CTD PMID:12421819 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of PRKCA mRNA CTD PMID:20426880 1,2-dimethylhydrazine decreases expression ISO RGD:737063 6480464 1, 2-Dimethylhydrazine results in decreased expression of PRKCA mRNA CTD PMID:22206623 , PMID:26388957 1,2-dimethylhydrazine multiple interactions ISO RGD:737063 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of PRKCA mRNA] CTD PMID:22206623 1-(5-isoquinolinesulfonyl)-2-methylpiperazine multiple interactions EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Heptachlor affects the localization of PRKCA protein], 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] CTD PMID:14678745 17alpha-ethynylestradiol affects expression ISO RGD:737063 6480464 Ethinyl Estradiol affects the expression of PRKCA mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PRKCA mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:737062 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PRKCA mRNA more ... CTD PMID:19619570 , PMID:23000059 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PRKCA mRNA CTD PMID:26496021 17beta-estradiol increases phosphorylation ISO RGD:737062 6480464 Estradiol results in increased phosphorylation of PRKCA protein CTD PMID:23000059 17beta-estradiol decreases activity ISO RGD:737062 6480464 Estradiol results in decreased activity of PRKCA protein CTD PMID:8946564 17beta-estradiol increases expression ISO RGD:737062 6480464 Estradiol results in increased expression of PRKCA mRNA CTD PMID:19619570 17beta-estradiol 17-glucosiduronic acid multiple interactions EXP 6480464 Go 6976 inhibits the reaction [estradiol-17 beta-glucuronide affects the localization of PRKCA protein] CTD PMID:18972403 17beta-estradiol 17-glucosiduronic acid affects localization EXP 6480464 estradiol-17 beta-glucuronide affects the localization of PRKCA protein CTD PMID:18972403 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:737062 6480464 Metribolone promotes the reaction [EZR protein binds to PRKCA protein], PRKCA protein affects the reaction [Metribolone results in increased phosphorylation of EZR protein] CTD PMID:16873375 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:737062 6480464 Dihydrotestosterone results in increased expression of PRKCA mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:16263226 2,2',4,4',5,5'-hexachlorobiphenyl increases activity EXP 6480464 2 more ... CTD PMID:16263226 2,2',4,4'-Tetrabromodiphenyl ether increases phosphorylation ISO RGD:737062 6480464 2 more ... CTD PMID:26988655 , PMID:28189027 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:737063 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737062 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PRKCA mRNA more ... CTD PMID:19121332 , PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKCA mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects activity ISO RGD:737062 6480464 Tetrachlorodibenzodioxin affects the activity of PRKCA protein CTD PMID:8946564 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737063 6480464 Tetrachlorodibenzodioxin affects the expression of PRKCA mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects localization ISO RGD:737062 6480464 Tetrachlorodibenzodioxin affects the localization of PRKCA protein CTD PMID:19121332 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737062 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKCA mRNA CTD PMID:19619570 , PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737062 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKCA mRNA CTD PMID:12377990 , PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which affects the localization of PRKCA protein CTD PMID:15761253 2,3,7,8-tetrachlorodibenzodioxine increases localization EXP 6480464 Tetrachlorodibenzodioxin results in increased localization of PRKCA protein CTD PMID:17222441 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737063 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKCA CTD PMID:17943652 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects localization ISO RGD:737062 6480464 2 more ... CTD PMID:15475174 2,6-di-tert-butyl-4-methylphenol decreases expression ISO RGD:737063 6480464 Butylated Hydroxytoluene results in decreased expression of PRKCA protein CTD PMID:7716780 2-methylcholine affects expression ISO RGD:737062 6480464 beta-methylcholine affects the expression of PRKCA mRNA CTD PMID:21179406 3,3',4,4'-tetrachlorobiphenyl increases activity EXP 6480464 3 more ... CTD PMID:16263226 3,3',4,4'-tetrachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:16263226 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:737063 6480464 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein] CTD PMID:20172950 3alpha-hydroxy-5beta-pregnan-20-one decreases expression ISO RGD:737063 6480464 Pregnanolone results in decreased expression of PRKCA protein CTD PMID:16581232 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of PRKCA mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol affects methylation ISO RGD:737063 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of PRKCA gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression ISO RGD:737062 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PRKCA protein CTD PMID:34186270 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of PRKCA mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide decreases expression ISO RGD:737063 6480464 Fenretinide results in decreased expression of PRKCA mRNA CTD PMID:28973697 5-(2-methylpiperazine-1-sulfonyl)isoquinoline multiple interactions EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Heptachlor affects the localization of PRKCA protein], 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] CTD PMID:14678745 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PRKCA mRNA CTD PMID:24780913 7,12-dimethyltetraphene multiple interactions EXP 6480464 Ghee inhibits the reaction [9 more ... CTD PMID:21088903 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:21088903 8-Br-cAMP increases expression ISO RGD:737062 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRKCA mRNA CTD PMID:22079614 acrylamide multiple interactions EXP 6480464 PRKCA protein affects the reaction [Acrylamide results in increased phosphorylation of MAPK1 protein] CTD PMID:33545342 aflatoxin B1 decreases expression ISO RGD:737062 6480464 Aflatoxin B1 results in decreased expression of PRKCA mRNA CTD PMID:21641981 aflatoxin B1 decreases methylation ISO RGD:737062 6480464 Aflatoxin B1 results in decreased methylation of PRKCA intron CTD PMID:30157460 Aflatoxin B2 alpha affects methylation ISO RGD:737062 6480464 aflatoxin B2 affects the methylation of PRKCA intron CTD PMID:30157460 aldehydo-D-glucose increases phosphorylation ISO RGD:737062 6480464 Glucose results in increased phosphorylation of PRKCA protein CTD PMID:22162761 aldehydo-D-glucose multiple interactions ISO RGD:737063 6480464 [Glucose co-treated with Silymarin] results in increased phosphorylation of PRKCA protein more ... CTD PMID:29753610 aldehydo-D-glucose multiple interactions EXP 6480464 Glucose promotes the reaction [zinc chloride affects the localization of and results in increased activity of PRKCA protein] CTD PMID:20800666 all-trans-retinoic acid multiple interactions ISO RGD:737062 6480464 PRKCA protein affects the reaction [Tretinoin results in increased activity of STS protein] CTD PMID:16178010 all-trans-retinoic acid increases expression ISO RGD:737062 6480464 Tretinoin results in increased expression of PRKCA mRNA CTD PMID:33167477 all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with Calcium] results in increased activity of PRKCA protein more ... CTD PMID:16114872 all-trans-retinoic acid increases phosphorylation ISO RGD:737063 6480464 Tretinoin results in increased phosphorylation of PRKCA protein CTD PMID:19476501 all-trans-retinoic acid increases expression ISO RGD:737063 6480464 Tretinoin results in increased expression of PRKCA mRNA, Tretinoin results in increased expression of PRKCA protein CTD PMID:11851873 , PMID:16505366 all-trans-retinoic acid multiple interactions ISO RGD:737063 6480464 AGN 193109 inhibits the reaction [Tretinoin results in increased expression of PRKCA mRNA] CTD PMID:16505366 all-trans-retinoic acid increases phosphorylation ISO RGD:737062 6480464 Tretinoin results in increased phosphorylation of PRKCA protein CTD PMID:19476501 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PRKCA mRNA CTD PMID:16483693 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of PRKCA protein CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of PRKCA mRNA CTD PMID:16101753 amphetamine multiple interactions EXP 6480464 PRKCA protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA] CTD PMID:16101753 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of PRKCA mRNA CTD PMID:30779732 amphetamine increases response to substance EXP 6480464 PRKCA protein results in increased susceptibility to Amphetamine CTD PMID:16101753 antirheumatic drug decreases expression ISO RGD:737062 6480464 Antirheumatic Agents results in decreased expression of PRKCA mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:737062 6480464 aristolochic acid I results in decreased expression of PRKCA mRNA CTD PMID:33212167 Aroclor 1254 affects localization ISO RGD:737062 6480464 Chlorodiphenyl (54% Chlorine) affects the localization of PRKCA protein CTD PMID:15475174 arsane affects methylation ISO RGD:737062 6480464 Arsenic affects the methylation of PRKCA gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:737062 6480464 Arsenic affects the methylation of PRKCA gene CTD PMID:25304211 arsenite(3-) increases expression ISO RGD:737063 6480464 arsenite results in increased expression of PRKCA mRNA CTD PMID:33053406 arsenous acid decreases expression ISO RGD:737063 6480464 Arsenic Trioxide results in decreased expression of PRKCA mRNA CTD PMID:24831965 arsenous acid affects response to substance ISO RGD:737062 6480464 PRKCA mRNA affects the susceptibility to Arsenic Trioxide CTD PMID:23911876 arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide promotes the reaction [Berberine results in decreased activity of PRKCA protein] CTD PMID:18294404 atorvastatin calcium multiple interactions EXP 6480464 [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of and results in increased phosphorylation of PRKCA protein] CTD PMID:32259528 ATP multiple interactions ISO RGD:737062 6480464 [[Adenosine Triphosphate co-treated with PRKCA protein] results in increased phosphorylation of RALBP1 protein] which results in increased transport of Doxorubicin CTD PMID:16087181 atrazine increases expression ISO RGD:737062 6480464 Atrazine results in increased expression of PRKCA mRNA CTD PMID:18585445 baicalein decreases phosphorylation ISO RGD:737062 6480464 baicalein results in decreased phosphorylation of PRKCA protein CTD PMID:21803068 beauvericin multiple interactions ISO RGD:737062 6480464 [beauvericin co-treated with enniatins] results in increased expression of PRKCA protein CTD PMID:32407736 benzene decreases expression ISO RGD:737062 6480464 Benzene results in decreased expression of PRKCA mRNA CTD PMID:33064461 benzo[a]pyrene decreases expression ISO RGD:737063 6480464 Benzo(a)pyrene results in decreased expression of PRKCA mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:737062 6480464 Benzo(a)pyrene affects the methylation of PRKCA intron CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:737063 6480464 Benzo(a)pyrene results in decreased methylation of PRKCA intron CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:737062 6480464 Benzo(a)pyrene results in decreased methylation of PRKCA 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:737062 6480464 Benzo(a)pyrene results in decreased expression of PRKCA mRNA CTD PMID:16269432 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:737062 6480464 7 more ... CTD PMID:19150397 , PMID:26238291 benzo[e]pyrene decreases methylation ISO RGD:737062 6480464 benzo(e)pyrene results in decreased methylation of PRKCA intron CTD PMID:30157460 berberine multiple interactions EXP 6480464 arsenic trioxide promotes the reaction [Berberine results in decreased activity of PRKCA protein], Berberine results in decreased activity of and affects the localization of PRKCA protein CTD PMID:18294404 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:737062 6480464 PRKCA protein affects the reaction [Diethylhexyl Phthalate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL12B protein]] CTD PMID:28673093 bisoprolol decreases expression EXP 6480464 Bisoprolol results in decreased expression of PRKCA protein CTD PMID:20668454 bisphenol A increases phosphorylation ISO RGD:737062 6480464 bisphenol A results in increased phosphorylation of PRKCA protein CTD PMID:22564983 bisphenol A multiple interactions ISO RGD:737062 6480464 [naringenin co-treated with bisphenol A] results in increased expression of PRKCA mRNA, [naringenin metabolite co-treated with bisphenol A] results in increased expression of PRKCA mRNA CTD PMID:36235125 bisphenol A decreases methylation ISO RGD:737062 6480464 bisphenol A results in decreased methylation of PRKCA gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PRKCA mRNA CTD PMID:29097150 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRKCA mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PRKCA mRNA, [Phytochemicals co-treated with bisphenol A] affects the expression of PRKCA CTD PMID:20136622 , PMID:26496021 Bisphenol B increases expression ISO RGD:737062 6480464 bisphenol B results in increased expression of PRKCA protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:737062 6480464 bisphenol F results in increased expression of PRKCA protein CTD PMID:34186270 brimonidine tartrate affects localization EXP 6480464 Brimonidine Tartrate affects the localization of PRKCA protein CTD PMID:12388232 brimonidine tartrate multiple interactions EXP 6480464 Nitric Oxide deficiency promotes the reaction [Brimonidine Tartrate affects the localization of PRKCA protein] CTD PMID:12388232 bryostatin 1 decreases expression ISO RGD:737062 6480464 bryostatin 1 results in decreased expression of PRKCA protein CTD PMID:8892972 bryostatin 1 multiple interactions ISO RGD:737062 6480464 [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCA protein CTD PMID:8892972 butan-1-ol multiple interactions EXP 6480464 [1-Butanol inhibits the reaction [PRKCA protein binds to PLD1 protein]] which results in decreased activity of PLD1 protein CTD PMID:15652502 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of PRKCA protein CTD PMID:25981801 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PRKCA protein CTD PMID:25981801 calcium atom multiple interactions EXP 6480464 [Tretinoin co-treated with Calcium] results in increased activity of PRKCA protein CTD PMID:16114872 calcium atom increases response to substance EXP 6480464 PRKCA protein results in increased susceptibility to Calcium CTD PMID:12388232 calcium(0) multiple interactions EXP 6480464 [Tretinoin co-treated with Calcium] results in increased activity of PRKCA protein CTD PMID:16114872 calcium(0) increases response to substance EXP 6480464 PRKCA protein results in increased susceptibility to Calcium CTD PMID:12388232 cannabidiol increases expression ISO RGD:737063 6480464 Cannabidiol results in increased expression of PRKCA mRNA CTD PMID:33019509 cannabigerol increases expression ISO RGD:737063 6480464 cannabigerol results in increased expression of PRKCA mRNA CTD PMID:33019509 capsaicin multiple interactions ISO RGD:737062 6480464 bisindolylmaleimide inhibits the reaction [Capsaicin results in increased expression of PRKCA protein] CTD PMID:21474332 capsaicin multiple interactions EXP 6480464 chelerythrine inhibits the reaction [Capsaicin results in increased expression of PRKCA protein], iodoresiniferatoxin inhibits the reaction [Capsaicin results in increased expression of PRKCA protein] CTD PMID:18752301 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of PRKCA mRNA, Capsaicin results in increased expression of PRKCA protein CTD PMID:18752301 capsaicin increases expression ISO RGD:737062 6480464 Capsaicin results in increased expression of PRKCA protein CTD PMID:21474332 carbamazepine affects expression ISO RGD:737062 6480464 Carbamazepine affects the expression of PRKCA mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO RGD:737063 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carvedilol decreases expression EXP 6480464 carvedilol results in decreased expression of PRKCA protein CTD PMID:20668454 celecoxib multiple interactions ISO RGD:737063 6480464 Celecoxib inhibits the reaction [deoxynivalenol affects the localization of PRKCA protein] CTD PMID:32416088 CGP 52608 multiple interactions ISO RGD:737062 6480464 CGP 52608 promotes the reaction [RORA protein binds to PRKCA gene] CTD PMID:28238834 chelerythrine multiple interactions EXP 6480464 chelerythrine inhibits the reaction [Capsaicin results in increased expression of PRKCA protein] CTD PMID:18752301 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of PRKCA mRNA CTD PMID:18668222 cisplatin multiple interactions ISO RGD:737062 6480464 [[PRKCA protein results in increased phosphorylation of GSTP1 protein] which results in increased metabolism of Cisplatin] which results in decreased susceptibility to Cisplatin more ... CTD PMID:20654585 , PMID:27392435 cisplatin decreases expression ISO RGD:737062 6480464 Cisplatin results in decreased expression of PRKCA mRNA CTD PMID:19561079 more ... clobetasol decreases expression ISO RGD:737063 6480464 Clobetasol results in decreased expression of PRKCA mRNA CTD PMID:27462272 cobalt dichloride decreases expression ISO RGD:737062 6480464 cobaltous chloride results in decreased expression of PRKCA mRNA CTD PMID:19320972 , PMID:19376846 cobalt dichloride multiple interactions EXP 6480464 cobaltous chloride results in increased oxidation of and results in increased activity of PRKCA protein CTD PMID:18375950 cocaine increases expression EXP 6480464 Cocaine results in increased expression of PRKCA protein CTD PMID:12808488 cocaine decreases expression ISO RGD:737063 6480464 Cocaine results in decreased expression of PRKCA mRNA CTD PMID:18355967 cocaine multiple interactions ISO RGD:737063 6480464 FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of PRKCA mRNA] CTD PMID:18355967 copper atom multiple interactions ISO RGD:737062 6480464 [Thiosemicarbazones binds to Copper] which results in decreased expression of PRKCA protein CTD PMID:20931265 copper atom decreases expression EXP 6480464 Copper deficiency results in decreased expression of PRKCA protein CTD PMID:11983831 copper(0) multiple interactions ISO RGD:737062 6480464 [Thiosemicarbazones binds to Copper] which results in decreased expression of PRKCA protein CTD PMID:20931265 copper(0) decreases expression EXP 6480464 Copper deficiency results in decreased expression of PRKCA protein CTD PMID:11983831 corticosterone multiple interactions ISO RGD:737063 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:16581232 coumarin increases phosphorylation ISO RGD:737062 6480464 coumarin results in increased phosphorylation of PRKCA protein CTD PMID:35688186 crocidolite asbestos increases activity ISO RGD:737063 6480464 Asbestos, Crocidolite results in increased activity of PRKCA protein CTD PMID:12626342 crocidolite asbestos increases expression ISO RGD:737063 6480464 Asbestos, Crocidolite results in increased expression of PRKCA protein CTD PMID:12626342 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of PRKCA mRNA CTD PMID:26577399 curcumin multiple interactions ISO RGD:737062 6480464 [PRKCA protein results in increased phosphorylation of CFTR protein] promotes the reaction [Curcumin results in increased activity of CFTR protein] CTD PMID:17178710 curcumin decreases expression ISO RGD:737062 6480464 Curcumin analog results in decreased expression of PRKCA mRNA CTD PMID:26409325 D-gluconic acid multiple interactions EXP 6480464 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PRKCA mRNA CTD PMID:16556975 D-glucose multiple interactions EXP 6480464 Glucose promotes the reaction [zinc chloride affects the localization of and results in increased activity of PRKCA protein] CTD PMID:20800666 D-glucose multiple interactions ISO RGD:737063 6480464 [Glucose co-treated with Silymarin] results in increased phosphorylation of PRKCA protein more ... CTD PMID:29753610 D-glucose increases phosphorylation ISO RGD:737062 6480464 Glucose results in increased phosphorylation of PRKCA protein CTD PMID:22162761 daidzein increases activity EXP 6480464 daidzein results in increased activity of PRKCA protein CTD PMID:16972265 dapagliflozin multiple interactions EXP 6480464 [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of and results in increased phosphorylation of PRKCA protein] CTD PMID:32259528 deoxycholic acid multiple interactions EXP 6480464 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PRKCA mRNA CTD PMID:16556975 deoxynivalenol multiple interactions ISO RGD:737063 6480464 Celecoxib inhibits the reaction [deoxynivalenol affects the localization of PRKCA protein], Ro 31-8220 inhibits the reaction [deoxynivalenol affects the localization of PRKCA protein] CTD PMID:32416088 deoxynivalenol affects localization ISO RGD:737063 6480464 deoxynivalenol affects the localization of PRKCA protein CTD PMID:32416088 dexamethasone affects expression ISO RGD:737062 6480464 Dexamethasone affects the expression of PRKCA mRNA CTD PMID:12732289 dextran sulfate multiple interactions ISO RGD:737063 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PRKCA mRNA CTD PMID:29950665 diarsenic trioxide affects response to substance ISO RGD:737062 6480464 PRKCA mRNA affects the susceptibility to Arsenic Trioxide CTD PMID:23911876 diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide promotes the reaction [Berberine results in decreased activity of PRKCA protein] CTD PMID:18294404 diarsenic trioxide decreases expression ISO RGD:737063 6480464 Arsenic Trioxide results in decreased expression of PRKCA mRNA CTD PMID:24831965 dibutyl phthalate increases expression ISO RGD:737063 6480464 Dibutyl Phthalate results in increased expression of PRKCA mRNA CTD PMID:17361019 , PMID:21266533 dichloroacetic acid increases expression ISO RGD:737063 6480464 Dichloroacetic Acid results in increased expression of PRKCA mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:737062 6480464 Diclofenac affects the expression of PRKCA mRNA CTD PMID:24752500 dicrotophos increases expression ISO RGD:737062 6480464 dicrotophos results in increased expression of PRKCA mRNA CTD PMID:28302478 diethylstilbestrol decreases expression ISO RGD:737063 6480464 Diethylstilbestrol results in decreased expression of PRKCA CTD PMID:17943652 dihydroartemisinin multiple interactions ISO RGD:737062 6480464 artenimol inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein], artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCA protein] CTD PMID:20152819 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of PRKCA mRNA CTD PMID:17481689 dimethylarsinous acid decreases expression ISO RGD:737062 6480464 dimethylarsinous acid results in decreased expression of PRKCA mRNA CTD PMID:16507463 disodium selenite multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PRKCA mRNA] CTD PMID:21705299 dizocilpine maleate multiple interactions ISO RGD:737063 6480464 Dizocilpine Maleate inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCA protein]] CTD PMID:18652891 dorsomorphin multiple interactions ISO RGD:737062 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:737063 6480464 Doxorubicin inhibits the reaction [Quercetin results in decreased expression of PRKCA protein] CTD PMID:15538571 doxorubicin multiple interactions ISO RGD:737062 6480464 [[Adenosine Triphosphate co-treated with PRKCA protein] results in increased phosphorylation of RALBP1 protein] which results in increased transport of Doxorubicin, PRKCA protein affects the reaction [RALBP1 protein affects the transport of and affects the susceptibility to Doxorubicin] CTD PMID:16087181 , PMID:16579994 emodin affects localization EXP 6480464 Emodin affects the localization of PRKCA protein CTD PMID:15133857 enalapril decreases expression EXP 6480464 Enalapril results in decreased expression of PRKCA protein modified form CTD PMID:21565836 enniatin multiple interactions ISO RGD:737062 6480464 [beauvericin co-treated with enniatins] results in increased expression of PRKCA protein CTD PMID:32407736 entinostat increases expression ISO RGD:737062 6480464 entinostat results in increased expression of PRKCA mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:737062 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCA mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:737062 6480464 [Ethanol results in increased localization of and results in increased activity of PRKCA protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] CTD PMID:10651808 ethanol affects splicing ISO RGD:737063 6480464 Ethanol affects the splicing of PRKCA mRNA CTD PMID:30319688 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PRKCA mRNA CTD PMID:20655511 ethanol multiple interactions EXP 6480464 Ethanol inhibits the reaction [Streptozocin results in increased expression of PRKCA protein] more ... CTD PMID:12198386 , PMID:20655511 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:737063 6480464 Egtazic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein] CTD PMID:20172950 Evodiamine increases phosphorylation ISO RGD:737063 6480464 evodiamine results in increased phosphorylation of PRKCA protein CTD PMID:19854188 Evodiamine multiple interactions ISO RGD:737063 6480464 EGFR mutant form inhibits the reaction [evodiamine results in increased phosphorylation of PRKCA protein], RTKI cpd inhibits the reaction [evodiamine results in increased phosphorylation of PRKCA protein] CTD PMID:19854188 fluticasone decreases expression ISO RGD:737062 6480464 Fluticasone results in decreased expression of PRKCA protein CTD PMID:15634547 folic acid multiple interactions ISO RGD:737063 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of PRKCA mRNA] CTD PMID:22206623 folic acid decreases expression ISO RGD:737063 6480464 Folic Acid results in decreased expression of PRKCA mRNA CTD PMID:25629700 folpet increases expression ISO RGD:737063 6480464 folpet results in increased expression of PRKCA mRNA CTD PMID:31558096 fructose multiple interactions EXP 6480464 [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of and results in increased phosphorylation of PRKCA protein], [Fructose co-treated with Dietary Fats] results in increased expression of and results in increased phosphorylation of PRKCA protein CTD PMID:32259528 gallic acid decreases activity ISO RGD:737062 6480464 Gallic Acid results in decreased activity of PRKCA protein CTD PMID:22387266 genistein increases expression ISO RGD:737062 6480464 Genistein results in increased expression of PRKCA mRNA CTD PMID:16705744 genistein decreases expression ISO RGD:737063 6480464 Genistein results in decreased expression of PRKCA mRNA CTD PMID:32186404 genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [lead acetate results in increased phosphorylation of PRKCA protein] CTD PMID:26797587 glucose multiple interactions EXP 6480464 Glucose promotes the reaction [zinc chloride affects the localization of and results in increased activity of PRKCA protein] CTD PMID:20800666 glucose multiple interactions ISO RGD:737063 6480464 [Glucose co-treated with Silymarin] results in increased phosphorylation of PRKCA protein more ... CTD PMID:29753610 glucose increases phosphorylation ISO RGD:737062 6480464 Glucose results in increased phosphorylation of PRKCA protein CTD PMID:22162761 glyphosate decreases methylation EXP 6480464 glyphosate results in decreased methylation of PRKCA gene CTD PMID:31011160 Goe 6976 decreases expression ISO RGD:737062 6480464 Go 6976 results in decreased expression of PRKCA mRNA CTD PMID:16374459 Goe 6976 multiple interactions ISO RGD:737062 6480464 Go 6976 inhibits the reaction [isophthalate analog affects the localization of PRKCA protein], Go 6976 results in decreased expression of and results in decreased activity of PRKCA protein CTD PMID:16374459 , PMID:23643828 Goe 6976 multiple interactions EXP 6480464 Go 6976 inhibits the reaction [estradiol-17 beta-glucuronide affects the localization of PRKCA protein] CTD PMID:18972403 Goe 6976 decreases phosphorylation ISO RGD:737063 6480464 Go 6976 results in decreased phosphorylation of PRKCA protein CTD PMID:19393235 heptachlor multiple interactions EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Heptachlor affects the localization of PRKCA protein] more ... CTD PMID:14678745 hydrogen cyanide decreases expression ISO RGD:737063 6480464 Hydrogen Cyanide results in decreased expression of PRKCA mRNA CTD PMID:33914522 hydrogen peroxide multiple interactions ISO RGD:737063 6480464 [PI103 co-treated with Hydrogen Peroxide] results in decreased expression of PRKCA protein, [Quercetin co-treated with Hydrogen Peroxide] results in decreased expression of PRKCA protein CTD PMID:27494022 hydrogen peroxide affects expression ISO RGD:737062 6480464 Hydrogen Peroxide affects the expression of PRKCA mRNA, Hydrogen Peroxide affects the expression of PRKCA protein CTD PMID:21179406 hydrogen peroxide increases phosphorylation ISO RGD:737062 6480464 Hydrogen Peroxide results in increased phosphorylation of PRKCA protein CTD PMID:19699794 hydrogen peroxide multiple interactions EXP 6480464 [Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of [PLD1 protein binds to PRKCA protein], [Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of PRKCA protein CTD PMID:15150437 hydrogen peroxide increases expression ISO RGD:737063 6480464 Hydrogen Peroxide results in increased expression of PRKCA protein CTD PMID:12626342 hydrogen peroxide increases activity ISO RGD:737063 6480464 Hydrogen Peroxide results in increased activity of PRKCA protein CTD PMID:12626342 imidaprilat multiple interactions ISO RGD:737063 6480464 imidaprilat inhibits the reaction [AGT protein results in increased activity of and results in increased localization of PRKCA protein] CTD PMID:16257180 irinotecan increases phosphorylation ISO RGD:737062 6480464 Irinotecan metabolite results in increased phosphorylation of PRKCA protein, Irinotecan results in increased phosphorylation of PRKCA protein CTD PMID:15723263 isophthalic acid affects localization ISO RGD:737062 6480464 isophthalate analog affects the localization of PRKCA protein CTD PMID:23643828 isophthalic acid multiple interactions ISO RGD:737062 6480464 Go 6976 inhibits the reaction [isophthalate analog affects the localization of PRKCA protein] CTD PMID:23643828 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of PRKCA mRNA, Isoproterenol results in increased expression of PRKCA protein CTD PMID:12775975 ivermectin decreases expression ISO RGD:737062 6480464 Ivermectin results in decreased expression of PRKCA protein CTD PMID:32959892 lead diacetate decreases expression ISO RGD:737062 6480464 lead acetate results in decreased expression of PRKCA protein CTD PMID:11861786 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of PRKCA protein CTD PMID:16547843 , PMID:25981801 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of PRKCA protein more ... CTD PMID:26797587 , PMID:36925031 lead diacetate increases phosphorylation EXP 6480464 lead acetate results in increased phosphorylation of PRKCA protein CTD PMID:26797587 lead diacetate increases expression ISO RGD:737063 6480464 lead acetate results in increased expression of PRKCA mRNA CTD PMID:22609695 lead diacetate multiple interactions ISO RGD:737062 6480464 4-((3-bromophenyl)amino)-6 more ... CTD PMID:11861786 , PMID:19133285 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of PRKCA protein more ... CTD PMID:19133285 , PMID:36925031 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of PRKCA protein CTD PMID:16547843 , PMID:25981801 leflunomide increases expression ISO RGD:737062 6480464 leflunomide results in increased expression of PRKCA mRNA CTD PMID:28988120 leptomycin B multiple interactions ISO RGD:737062 6480464 [leptomycin B co-treated with TP53 gene mutant form] results in decreased expression of PRKCA mRNA CTD PMID:20803015 linsidomine multiple interactions EXP 6480464 [linsidomine co-treated with Staurosporine] results in decreased expression of PRKCA protein, Staurosporine inhibits the reaction [linsidomine results in increased phosphorylation of PRKCA protein] CTD PMID:11994256 lipopolysaccharide multiple interactions ISO RGD:737063 6480464 Lipopolysaccharides affects the localization of and results in increased activity of PRKCA protein, PRKCA promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein] CTD PMID:16330529 , PMID:22102721 lithium atom increases response to substance ISO RGD:737063 6480464 PRKCA gene results in increased susceptibility to Lithium CTD PMID:25006961 lithium atom decreases response to substance ISO RGD:737063 6480464 PRKCA gene mutant form results in decreased susceptibility to Lithium CTD PMID:25006961 lithium atom multiple interactions ISO RGD:737063 6480464 PRKCA gene mutant form inhibits the reaction [Lithium results in decreased expression of AQP2 protein], PRKCA gene mutant form inhibits the reaction [Lithium results in decreased expression of SLC14A2 protein] CTD PMID:25006961 lithium hydride multiple interactions ISO RGD:737063 6480464 PRKCA gene mutant form inhibits the reaction [Lithium results in decreased expression of AQP2 protein], PRKCA gene mutant form inhibits the reaction [Lithium results in decreased expression of SLC14A2 protein] CTD PMID:25006961 lithium hydride decreases response to substance ISO RGD:737063 6480464 PRKCA gene mutant form results in decreased susceptibility to Lithium CTD PMID:25006961 lithium hydride increases response to substance ISO RGD:737063 6480464 PRKCA gene results in increased susceptibility to Lithium CTD PMID:25006961 luteolin multiple interactions ISO RGD:737062 6480464 Luteolin analog inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] CTD PMID:30133131 manganese atom increases phosphorylation EXP 6480464 Manganese results in increased phosphorylation of PRKCA protein CTD PMID:21812036 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of PRKCA protein CTD PMID:25981801 manganese(0) increases phosphorylation EXP 6480464 Manganese results in increased phosphorylation of PRKCA protein CTD PMID:21812036 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of PRKCA protein CTD PMID:25981801 manganese(II) chloride multiple interactions EXP 6480464 1 more ... CTD PMID:17084486 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of PRKCA protein CTD PMID:25981801 manganese(II) chloride increases activity EXP 6480464 manganese chloride results in increased activity of PRKCA protein CTD PMID:17084486 manganese(II) chloride affects localization EXP 6480464 manganese chloride affects the localization of PRKCA protein CTD PMID:17084486 mercury atom increases expression EXP 6480464 Mercury results in increased expression of PRKCA mRNA CTD PMID:12730625 mercury(0) increases expression EXP 6480464 Mercury results in increased expression of PRKCA mRNA CTD PMID:12730625 metformin multiple interactions ISO RGD:737062 6480464 [Metformin co-treated with Pioglitazone] results in decreased expression of PRKCA mRNA, Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCA protein] CTD PMID:20590612 , PMID:32589349 metformin decreases expression ISO RGD:737062 6480464 Metformin results in decreased expression of PRKCA mRNA CTD PMID:32589349 methamphetamine multiple interactions ISO RGD:737062 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:33421459 methamphetamine increases expression ISO RGD:737062 6480464 Methamphetamine results in increased expression of PRKCA mRNA, Methamphetamine results in increased expression of PRKCA protein CTD PMID:33421459 methapyrilene decreases methylation ISO RGD:737062 6480464 Methapyrilene results in decreased methylation of PRKCA intron CTD PMID:30157460 methotrexate decreases response to substance ISO RGD:737062 6480464 PRKCA mRNA results in decreased susceptibility to Methotrexate CTD PMID:18694510 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of PRKCA mRNA CTD PMID:23303685 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of PRKCA gene CTD PMID:35440735 methylarsonic acid increases expression EXP 6480464 monomethylarsonic acid results in increased expression of PRKCA mRNA CTD PMID:17481689 methylseleninic acid increases expression ISO RGD:737062 6480464 methylselenic acid results in increased expression of PRKCA mRNA CTD PMID:12517777 methyltestosterone multiple interactions ISO RGD:737062 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of PRKCA mRNA CTD PMID:27344345 Mezerein multiple interactions ISO RGD:737062 6480464 [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCA protein CTD PMID:8892972 mianserin decreases expression ISO RGD:737062 6480464 Mianserin results in decreased expression of PRKCA mRNA CTD PMID:24154490 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of PRKCA mRNA CTD PMID:36657700 mifepristone multiple interactions ISO RGD:737063 6480464 Mifepristone binds to and results in decreased activity of PRKCA protein CTD PMID:16581232 miltefosine decreases phosphorylation ISO RGD:737062 6480464 miltefosine results in decreased phosphorylation of PRKCA protein CTD PMID:31265827 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:737063 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of PRKCA mRNA CTD PMID:22401849 morphine multiple interactions ISO RGD:737063 6480464 Dizocilpine Maleate inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCA protein]] more ... CTD PMID:18652891 mycophenolic acid increases expression ISO RGD:737062 6480464 Mycophenolic Acid results in increased expression of PRKCA protein CTD PMID:21396949 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PRKCA gene CTD PMID:33148267 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases activity ISO RGD:737062 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of PRKCA protein CTD PMID:16361081 N-methyl-4-phenylpyridinium affects expression ISO RGD:737062 6480464 1-Methyl-4-phenylpyridinium affects the expression of PRKCA mRNA CTD PMID:12710931 N-nitrosodiethylamine multiple interactions ISO RGD:737063 6480464 Diethylnitrosamine results in increased phosphorylation of and results in increased activity of PRKCA protein, MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of PRKCA protein] CTD PMID:17942915 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of PRKCA mRNA, Diethylnitrosamine results in increased expression of PRKCA protein CTD PMID:17106253 , PMID:28804948 N-nitrosodiethylamine multiple interactions EXP 6480464 bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of PRKCA mRNA], Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased expression of PRKCA protein] CTD PMID:17106253 , PMID:28804948 nickel atom increases expression ISO RGD:737062 6480464 Nickel results in increased expression of PRKCA mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression ISO RGD:737062 6480464 nickel chloride results in increased expression of PRKCA mRNA CTD PMID:17312168 nicotine increases activity ISO RGD:737062 6480464 Nicotine results in increased activity of PRKCA protein CTD PMID:12421819 nicotine increases expression EXP 6480464 Nicotine results in increased expression of PRKCA mRNA CTD PMID:20426880 nimodipine multiple interactions EXP 6480464 Nimodipine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of PRKCA protein] CTD PMID:36925031 nitric oxide multiple interactions EXP 6480464 Nitric Oxide deficiency promotes the reaction [Brimonidine Tartrate affects the localization of PRKCA protein] CTD PMID:12388232 o-cresol increases expression EXP 6480464 2-cresol results in increased expression of PRKCA mRNA CTD PMID:21705299 o-cresol multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PRKCA mRNA] CTD PMID:21705299 obeticholic acid increases expression ISO RGD:737062 6480464 obeticholic acid results in increased expression of PRKCA mRNA CTD PMID:27939613 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of PRKCA mRNA CTD PMID:12700408 p-cresol increases phosphorylation EXP 6480464 4-cresol results in increased phosphorylation of PRKCA protein CTD PMID:22813906 p-cresol increases response to substance EXP 6480464 PRKCA protein results in increased susceptibility to 4-cresol CTD PMID:22813906 p-cresol multiple interactions EXP 6480464 1 more ... CTD PMID:22813906 , PMID:23466501 panobinostat multiple interactions ISO RGD:737062 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCA mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:737062 6480464 panobinostat results in increased expression of PRKCA mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:737062 6480464 Acetaminophen results in decreased expression of PRKCA mRNA CTD PMID:21420995 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PRKCA mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:737062 6480464 Acetaminophen results in increased expression of PRKCA mRNA CTD PMID:25704631 , PMID:29067470 paricalcitol multiple interactions EXP 6480464 paricalcitol inhibits the reaction [EDN1 protein results in increased expression of PRKCA protein modified form], paricalcitol inhibits the reaction [Phenylephrine results in increased expression of PRKCA protein modified form] CTD PMID:21565836 paricalcitol decreases expression EXP 6480464 paricalcitol results in decreased expression of PRKCA protein modified form CTD PMID:21565836 perfluorooctane-1-sulfonic acid affects expression ISO RGD:737063 6480464 perfluorooctane sulfonic acid affects the expression of PRKCA mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:737063 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PRKCA mRNA CTD PMID:36331819 perfluorooctanoic acid affects expression ISO RGD:737063 6480464 perfluorooctanoic acid affects the expression of PRKCA mRNA CTD PMID:19429403 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PRKCA gene CTD PMID:33148267 phenethyl isothiocyanate multiple interactions ISO RGD:737062 6480464 phenethyl isothiocyanate results in decreased phosphorylation of and results in decreased expression of PRKCA protein CTD PMID:26456889 phenobarbital affects expression ISO RGD:737063 6480464 Phenobarbital affects the expression of PRKCA mRNA CTD PMID:19136022 phenylephrine multiple interactions ISO RGD:737063 6480464 DGKE protein inhibits the reaction [Phenylephrine results in increased localization of PRKCA protein], Diglycerides affects the reaction [Phenylephrine results in increased localization of PRKCA protein] CTD PMID:18487437 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of PRKCA protein modified form CTD PMID:21565836 phenylephrine multiple interactions EXP 6480464 GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCA protein] more ... CTD PMID:16809552 , PMID:21565836 phenylephrine increases activity EXP 6480464 Phenylephrine results in increased activity of PRKCA protein CTD PMID:12435817 phenylephrine increases localization ISO RGD:737063 6480464 Phenylephrine results in increased localization of PRKCA protein CTD PMID:18487437 phenylmercury acetate increases expression ISO RGD:737062 6480464 Phenylmercuric Acetate results in increased expression of PRKCA mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737062 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCA mRNA CTD PMID:27188386 phorbol 12,13-dibutanoate decreases expression ISO RGD:737062 6480464 Phorbol 12, 13-Dibutyrate results in decreased expression of PRKCA protein CTD PMID:17171646 phorbol 12,13-dibutanoate multiple interactions EXP 6480464 Phorbol 12, 13-Dibutyrate results in decreased expression of and affects the localization of PRKCA protein CTD PMID:9242432 phorbol 12,13-dibutanoate increases expression ISO RGD:737063 6480464 Phorbol 12, 13-Dibutyrate results in increased expression of PRKCA protein CTD PMID:12626342 phorbol 13-acetate 12-myristate decreases expression ISO RGD:737062 6480464 Tetradecanoylphorbol Acetate results in decreased expression of PRKCA protein CTD PMID:15330761 more ... phorbol 13-acetate 12-myristate increases phosphorylation ISO RGD:737062 6480464 Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCA protein CTD PMID:20152819 more ... phorbol 13-acetate 12-myristate affects localization ISO RGD:737062 6480464 Tetradecanoylphorbol Acetate affects the localization of PRKCA protein CTD PMID:15976015 more ... phorbol 13-acetate 12-myristate increases activity ISO RGD:737063 6480464 Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein CTD PMID:20172950 phorbol 13-acetate 12-myristate affects localization EXP 6480464 Tetradecanoylphorbol Acetate affects the localization of PRKCA protein CTD PMID:12720544 more ... phorbol 13-acetate 12-myristate decreases expression EXP 6480464 Tetradecanoylphorbol Acetate results in decreased expression of PRKCA protein CTD PMID:12590138 phorbol 13-acetate 12-myristate increases activity ISO RGD:737062 6480464 Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein CTD PMID:21705328 phorbol 13-acetate 12-myristate increases expression ISO RGD:737062 6480464 Tetradecanoylphorbol Acetate results in increased expression of PRKCA protein modified form CTD PMID:16532021 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] more ... CTD PMID:12590138 more ... phorbol 13-acetate 12-myristate increases localization ISO RGD:737063 6480464 Tetradecanoylphorbol Acetate results in increased localization of PRKCA protein CTD PMID:10656618 phorbol 13-acetate 12-myristate increases expression ISO RGD:737063 6480464 Tetradecanoylphorbol Acetate results in increased expression of PRKCA mRNA CTD PMID:17106253 phorbol 13-acetate 12-myristate affects localization ISO RGD:737063 6480464 Tetradecanoylphorbol Acetate affects the localization of PRKCA protein CTD PMID:16343552 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:737063 6480464 4-(5-benzo(1 more ... CTD PMID:16099101 more ... phorbol 13-acetate 12-myristate decreases phosphorylation ISO RGD:737062 6480464 Tetradecanoylphorbol Acetate results in decreased phosphorylation of PRKCA protein CTD PMID:15380616 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:737062 6480464 [Ethanol results in increased localization of and results in increased activity of PRKCA protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] more ... CTD PMID:10651808 more ... pioglitazone multiple interactions ISO RGD:737062 6480464 [Metformin co-treated with Pioglitazone] results in decreased expression of PRKCA mRNA CTD PMID:32589349 pioglitazone decreases expression ISO RGD:737062 6480464 Pioglitazone results in decreased expression of PRKCA mRNA CTD PMID:32589349 piperine multiple interactions ISO RGD:737062 6480464 piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and affects the localization of PRKCA protein] CTD PMID:21354279 pirinixic acid affects expression ISO RGD:737063 6480464 pirinixic acid affects the expression of PRKCA mRNA CTD PMID:19136022 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PRKCA mRNA CTD PMID:12832660 pirinixic acid increases expression ISO RGD:737063 6480464 pirinixic acid results in increased expression of PRKCA mRNA CTD PMID:20813756 procyanidin B2 multiple interactions EXP 6480464 procyanidin B2 inhibits the reaction [Streptozocin results in increased expression of PRKCA protein] CTD PMID:25199697 progesterone decreases phosphorylation ISO RGD:737063 6480464 Progesterone results in decreased phosphorylation of PRKCA protein CTD PMID:18615583 progesterone multiple interactions ISO RGD:737063 6480464 PRKCA protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased expression of and results in increased phosphorylation of STAR protein] which results in increased abundance of Progesterone], Progesterone inhibits the reaction [C3 protein results in increased phosphorylation of PRKCA protein] CTD PMID:18615583 , PMID:21047949 propranolol decreases expression EXP 6480464 Propranolol results in decreased expression of PRKCA protein CTD PMID:20668454 quercetin decreases expression ISO RGD:737062 6480464 Quercetin results in decreased expression of PRKCA protein CTD PMID:26311153 quercetin decreases expression ISO RGD:737063 6480464 Quercetin results in decreased expression of PRKCA more ... CTD PMID:15538571 more ... quercetin multiple interactions ISO RGD:737063 6480464 [Quercetin co-treated with Hydrogen Peroxide] results in decreased expression of PRKCA protein, Doxorubicin inhibits the reaction [Quercetin results in decreased expression of PRKCA protein] CTD PMID:15538571 , PMID:27494022 reactive oxygen species multiple interactions EXP 6480464 Reactive Oxygen Species affects the reaction [manganese chloride results in increased activity of PRKCA protein] CTD PMID:17084486 resveratrol multiple interactions ISO RGD:737062 6480464 PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] more ... CTD PMID:14739659 more ... resveratrol decreases expression ISO RGD:737063 6480464 resveratrol results in decreased expression of PRKCA protein CTD PMID:25505154 resveratrol decreases activity ISO RGD:737062 6480464 resveratrol results in decreased activity of PRKCA protein CTD PMID:11709203 riddelliine increases expression EXP 6480464 riddelliine results in increased expression of PRKCA mRNA CTD PMID:18047727 ritonavir multiple interactions ISO RGD:737063 6480464 Ritonavir binds to and affects the localization of PRKCA protein CTD PMID:22020176 ritonavir increases activity ISO RGD:737063 6480464 Ritonavir results in increased activity of PRKCA protein CTD PMID:22020176 ritonavir increases expression ISO RGD:737063 6480464 Ritonavir results in increased expression of PRKCA protein CTD PMID:22020176 Ro 31-8220 multiple interactions ISO RGD:737063 6480464 Ro 31-8220 inhibits the reaction [deoxynivalenol affects the localization of PRKCA protein] CTD PMID:32416088 Ro 31-8220 multiple interactions EXP 6480464 Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of PRKCA protein] CTD PMID:36925031 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PRKCA mRNA CTD PMID:28374803 S-butyl-DL-homocysteine (S,R)-sulfoximine decreases activity EXP 6480464 Buthionine Sulfoximine results in decreased activity of PRKCA protein CTD PMID:11118818 S-nitroso-N-acetyl-D-penicillamine multiple interactions ISO RGD:737063 6480464 S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCA protein] CTD PMID:18652891 SB 431542 multiple interactions ISO RGD:737063 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein] CTD PMID:20172950 SB 431542 multiple interactions ISO RGD:737062 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:737063 6480464 Silicon Dioxide results in decreased expression of PRKCA mRNA CTD PMID:23221170 sirolimus multiple interactions ISO RGD:737062 6480464 Sirolimus inhibits the reaction [Estradiol results in increased phosphorylation of PRKCA protein] CTD PMID:23000059 sodium arsenite decreases expression ISO RGD:737062 6480464 sodium arsenite results in decreased expression of PRKCA mRNA CTD PMID:16507463 sodium arsenite multiple interactions ISO RGD:737062 6480464 sodium arsenite promotes the reaction [PRKCA protein binds to CAPRIN1 protein] CTD PMID:33939924 sodium arsenite multiple interactions EXP 6480464 sodium arsenite promotes the reaction [AGO2 protein binds to PRKCA protein] CTD PMID:30404558 sodium arsenite increases expression ISO RGD:737062 6480464 sodium arsenite results in increased expression of PRKCA mRNA CTD PMID:12016162 sodium chloride increases expression ISO RGD:737062 6480464 Sodium Chloride results in increased expression of PRKCA mRNA CTD PMID:23634900 sorafenib decreases expression ISO RGD:737062 6480464 sorafenib results in decreased expression of PRKCA mRNA CTD PMID:26409325 staurosporine multiple interactions ISO RGD:737062 6480464 Staurosporine affects the localization of and affects the activity of PRKCA protein CTD PMID:16225760 staurosporine multiple interactions EXP 6480464 [linsidomine co-treated with Staurosporine] results in decreased expression of PRKCA protein more ... CTD PMID:11994256 , PMID:14678745 streptozocin multiple interactions EXP 6480464 Ethanol inhibits the reaction [Streptozocin results in increased expression of PRKCA protein], procyanidin B2 inhibits the reaction [Streptozocin results in increased expression of PRKCA protein] CTD PMID:12198386 , PMID:25199697 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of PRKCA protein CTD PMID:12198386 , PMID:25199697 SU6656 multiple interactions ISO RGD:737062 6480464 SU 6656 inhibits the reaction [lead acetate results in increased activity of PRKCA protein] CTD PMID:19133285 sulforaphane increases expression ISO RGD:737062 6480464 sulforaphane results in increased expression of PRKCA mRNA CTD PMID:26833863 superoxide multiple interactions ISO RGD:737062 6480464 [Ethanol results in increased localization of and results in increased activity of PRKCA protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] CTD PMID:10651808 tamoxifen affects expression ISO RGD:737063 6480464 Tamoxifen affects the expression of PRKCA mRNA CTD PMID:17555576 tamoxifen decreases phosphorylation ISO RGD:737063 6480464 Tamoxifen results in decreased phosphorylation of PRKCA protein CTD PMID:19393235 taurine decreases expression EXP 6480464 Taurine results in decreased expression of PRKCA protein CTD PMID:18822960 temozolomide decreases expression ISO RGD:737062 6480464 Temozolomide results in decreased expression of PRKCA mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:737062 6480464 tert-Butylhydroperoxide results in decreased expression of PRKCA mRNA CTD PMID:15336504 tert-butyl hydroperoxide increases activity EXP 6480464 tert-Butylhydroperoxide results in increased activity of PRKCA protein CTD PMID:16716901 tert-butyl hydroperoxide affects localization EXP 6480464 tert-Butylhydroperoxide affects the localization of PRKCA protein CTD PMID:16716901 testosterone multiple interactions ISO RGD:737063 6480464 Testosterone inhibits the reaction [C3 protein results in increased phosphorylation of PRKCA protein] CTD PMID:18615583 testosterone decreases phosphorylation ISO RGD:737063 6480464 Testosterone results in decreased phosphorylation of PRKCA protein CTD PMID:18615583 testosterone enanthate decreases expression EXP 6480464 testosterone enanthate results in decreased expression of PRKCA mRNA CTD PMID:25603467 testosterone undecanoate increases expression ISO RGD:737062 6480464 testosterone undecanoate results in increased expression of PRKCA mRNA CTD PMID:19074003 tetrachloroethene increases expression ISO RGD:737063 6480464 Tetrachloroethylene results in increased expression of PRKCA mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PRKCA mRNA CTD PMID:31150632 tetrahydropalmatine decreases expression ISO RGD:737062 6480464 tetrahydropalmatine results in decreased expression of PRKCA protein CTD PMID:20109541 thapsigargin increases expression ISO RGD:737063 6480464 Thapsigargin results in increased expression of PRKCA protein CTD PMID:24648495 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of PRKCA protein CTD PMID:35544339 thapsigargin decreases expression ISO RGD:737062 6480464 Thapsigargin results in decreased expression of PRKCA mRNA CTD PMID:22378314 theophylline decreases expression ISO RGD:737062 6480464 Theophylline results in decreased expression of PRKCA mRNA CTD PMID:16083514 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PRKCA mRNA CTD PMID:23411599 thiram decreases activity ISO RGD:737062 6480464 Thiram results in decreased activity of PRKCA protein CTD PMID:15998240 titanium dioxide multiple interactions ISO RGD:737063 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PRKCA mRNA CTD PMID:29950665 tributylstannane decreases expression ISO RGD:737062 6480464 tributyltin results in decreased expression of PRKCA mRNA CTD PMID:27678064 trichostatin A increases expression ISO RGD:737062 6480464 trichostatin A results in increased expression of PRKCA mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:737062 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCA mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:737063 6480464 trimellitic anhydride results in increased expression of PRKCA mRNA CTD PMID:19042947 trimethylarsine oxide increases expression EXP 6480464 trimethylarsine oxide results in increased expression of PRKCA mRNA CTD PMID:17481689 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PRKCA protein CTD PMID:32519852 tunicamycin increases expression ISO RGD:737063 6480464 Tunicamycin results in increased expression of PRKCA mRNA CTD PMID:17127020 tyrphostin AG 1478 multiple interactions ISO RGD:737063 6480464 RTKI cpd inhibits the reaction [evodiamine results in increased phosphorylation of PRKCA protein] CTD PMID:19854188 U-73122 multiple interactions ISO RGD:737063 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:16581232 U-73122 multiple interactions ISO RGD:737062 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:19281832 , PMID:33421459 urethane multiple interactions ISO RGD:737063 6480464 IFNG protein inhibits the reaction [Urethane results in decreased expression of PRKCA mRNA] CTD PMID:11091364 urethane increases expression ISO RGD:737062 6480464 Urethane results in increased expression of PRKCA mRNA CTD PMID:28818685 urethane decreases expression ISO RGD:737063 6480464 Urethane results in decreased expression of PRKCA mRNA CTD PMID:11091364 valproic acid affects expression ISO RGD:737063 6480464 Valproic Acid affects the expression of PRKCA mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:737062 6480464 Valproic Acid results in increased expression of PRKCA mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO RGD:737062 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCA mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:737062 6480464 Valproic Acid results in decreased expression of PRKCA mRNA CTD PMID:25192806 valproic acid affects expression ISO RGD:737062 6480464 Valproic Acid affects the expression of PRKCA mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:737062 6480464 Valproic Acid results in increased methylation of PRKCA gene CTD PMID:29154799 , PMID:29501571 valproic acid decreases expression ISO RGD:737063 6480464 Valproic Acid results in decreased expression of PRKCA protein CTD PMID:15249158 vanadium atom multiple interactions ISO RGD:737063 6480464 PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein], PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] CTD PMID:14971662 vanadium(0) multiple interactions ISO RGD:737063 6480464 PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein], PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] CTD PMID:14971662 vitamin D multiple interactions ISO RGD:737063 6480464 Vitamin D inhibits the reaction [Dust results in increased activity of PRKCA protein] CTD PMID:23281135 vorinostat multiple interactions ISO RGD:737062 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCA mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:737062 6480464 vorinostat results in increased expression of PRKCA mRNA CTD PMID:26272509 zinc atom multiple interactions ISO RGD:737062 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PRKCA mRNA CTD PMID:18593933 zinc atom multiple interactions ISO RGD:737063 6480464 calphostin C inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCA protein]], Zinc promotes the reaction [OPRM1 protein binds to PRKCA protein] CTD PMID:18652891 zinc dichloride multiple interactions EXP 6480464 1 more ... CTD PMID:20800666 , PMID:21575692 zinc dichloride affects localization EXP 6480464 zinc chloride affects the localization of PRKCA protein CTD PMID:21575692 zinc(0) multiple interactions ISO RGD:737062 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PRKCA mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:737063 6480464 calphostin C inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCA protein]], Zinc promotes the reaction [OPRM1 protein binds to PRKCA protein] CTD PMID:18652891
